Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
images Send Inquiry
Request To Call Back

Bryxta-400 BEVACIZUMAB 400mg Injection

Price 63995.0 INR/ Bottle

Get a Price/Quote
MOQ : 100 Packs

Bryxta-400 BEVACIZUMAB 400mg Injection Specification

  • Origin
  • India
  • Salt Composition
  • Bevacizumab
  • Dosage Form
  • Injection
  • Indication
  • Cancer treatment
  • Storage Instructions
  • Cool and dry place
  • Shelf Life
  • 12 Months
 

Bryxta-400 BEVACIZUMAB 400mg Injection Trade Information

  • Minimum Order Quantity
  • 100 Packs
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Packs Per Month
  • Delivery Time
  • 7-10 Days
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India
 

About Bryxta-400 BEVACIZUMAB 400mg Injection



Bryxta-400 BEVACIZUMAB 400mg Injection is a scarce and highly in-demand oncology solution, meticulously crafted to address cancer treatment requirements with unmatchable precision. Originating from India, this wondrous pharmaceutical marvel contains Bevacizumab as its potent salt composition, establishing its reputation for astonishing efficacy. Supplied by leading exporters and suppliers, Bryxta-400 offers the option to personalise care based on patient need. Safe storage in a cool, dry place ensures its effectiveness throughout its 12-month shelf life. Experience a breakthrough in cancer therapy with this exceptional injection.

Exceptional Application & Innovative Features

Bryxta-400 BEVACIZUMAB 400mg Injection is specially designed for oncology applications, targeting various types of cancer. Its core ingredient, Bevacizumab, makes it suitable for hospital and clinical plant environments where advanced cancer care is delivered. This injection is recognised for its reliable efficacy, consistent performance, and stringent quality controls. Each batch is developed to offer unparalleled results, ensuring both safety and satisfaction in high-stakes therapeutic environments for patients across India and beyond.


Extensive Market Presence & Swift Delivery Solutions

Bryxta-400 BEVACIZUMAB 400mg Injection is widely available in the main domestic market and is actively shipped to major international destinations. Meticulous attention to packing & dispatch standards guarantees that each shipment maintains optimal quality and arrives intact. Whether ordering samples or larger volumes, products are securely delivered through reliable logistical channels to meet urgent medical needs. We prioritise customer confidence with efficient order tracking and prompt fulfilment for clients worldwide.


FAQ's of Bryxta-400 BEVACIZUMAB 400mg Injection:


Q: How should Bryxta-400 BEVACIZUMAB 400mg Injection be stored?

A: Bryxta-400 BEVACIZUMAB 400mg Injection must be stored in a cool and dry place to maintain its efficacy and extend shelf life up to 12 months.

Q: What is the primary benefit of using Bryxta-400 BEVACIZUMAB 400mg Injection?

A: The primary benefit is its targeted action against cancer, offering an unmatchable, well-established treatment option for patients requiring advanced oncological care.

Q: When is this injection recommended for use?

A: Bryxta-400 is recommended upon a physician's advice, typically as part of a cancer treatment regimen suited to the patient's clinical profile.

Q: Where is Bryxta-400 BEVACIZUMAB 400mg Injection manufactured and supplied from?

A: This injection is manufactured and supplied from India, with a strong presence as both an exporter and domestic supplier.

Q: What is the process for shipment and delivery of Bryxta-400 BEVACIZUMAB?

A: Orders are carefully packed and dispatched, ensuring each shipment meets stringent standards. Products are delivered safely, both domestically and internationally, with tracking available.

Q: How can clinicians personalise the usage of Bryxta-400 BEVACIZUMAB?

A: Clinicians can personalise the dosage and administration based on the patient's cancer type, clinical needs, and response to therapy, optimising treatment outcomes.

Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Bryxta-400 BEVACIZUMAB 400mg Injection
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

Rolimus Everolimus Tablet 10 mg

Rolimus Everolimus Tablet 10 mg

Price 11434.5 INR / Piece

Minimum Order Quantity : 100 Packs

Storage Instructions : Cool and dry place

Origin : India

Dosage Form : Tablets

Salt Composition : Everolimus

Get a Price/Quote
Zecyte Abiraterone Acetate Tablets 250mg

Zecyte Abiraterone Acetate Tablets 250mg

Price 19500.0 INR / Box

Minimum Order Quantity : 100 Packs

Storage Instructions : Cool and dry place

Origin : India

Dosage Form : Tablets

Salt Composition : Abiraterone Acetate

Get a Price/Quote
Erlocip Erlotinib 150 Mg Tablets

Erlocip Erlotinib 150 Mg Tablets

Price 9502.06 INR / Bottle

Minimum Order Quantity : 100 Packs

Storage Instructions : Cool and dry place

Origin : India

Dosage Form : Tablets

Salt Composition : Erlotinib

Get a Price/Quote
Arpimune ME Ciclosporin Capsule 100mg

Arpimune ME Ciclosporin Capsule 100mg

Price 406.3 INR / Box

Minimum Order Quantity : 100 Packs

Storage Instructions : Cool and dry place

Origin : India

Dosage Form : Capsules

Salt Composition : Ciclosporin

Get a Price/Quote


Contact Details

GST : 27AAYFK6141L1ZL

  • 4th Floor, Ganjipeth Shop No 412, Central Avenue R, Sandesh Dawa Bazaar, Nagpur - 440018, Maharashtra, India
  • Phone :08071931667
  • Mr Siddharth (Partner)
  • Mobile :08071931667
Send Inquiry
Send SMS
   
Call Me Free

Quick Links
Back to top
logo
K T Agencies All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Change Language